Evidence map›Paper›PMID 31109373›Full record

ReviewDiagnostic pathology2019

Tumor-to-tumor metastasis: a rare case of breast carcinoma metastasizing to a pheochromocytoma, and a literature review.

Weiwei Tan, Lili Tao, Zhuping Zhou, Weihua Yin, Yaoli Chen

Abstract readCase ReportsReview
In one paragraph

Review in Diagnostic pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Weiwei TanDepartment of Pathology, Peking University Shenzhen Hospital, Shenzhen, Guangdong Province, People's Republic of China.
Lili TaoDepartment of Pathology, Peking University Shenzhen Hospital, Shenzhen, Guangdong Province, People's Republic of China. 651055473@qq.com.
Zhuping ZhouDepartment of Imaging, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University, Nanjing, Jiangsu Province, People's Republic of China.
Weihua YinDepartment of Pathology, Peking University Shenzhen Hospital, Shenzhen, Guangdong Province, People's Republic of China.
Yaoli ChenDepartment of Pathology, Peking University Shenzhen Hospital, Shenzhen, Guangdong Province, People's Republic of China.

Funding

the "San-ming" Project of Medicine in Shenzhen NO. SZSM201812088the Science and Research Foundation of Peking University, Shenzhen Hospital NO. JCYJ201710
6 · The paper itself

Abstract

backgroundTumor-to-tumor metastasis is a well-recognized but uncommon entity. Breast carcinoma is one of the most common metastatic donors. Breast carcinoma metastasizes commonly to adrenal glands. However, the co-existence of a metastatic lesion with an existing adrenal tumor is a rare finding. CASE PRESENTATION: A 35-year-old woman was diagnosed with pheochromocytoma using computed tomography and ultrasound examinations. The tumor was surgically removed. Histological and immunohistochemical staining suggested that there were two components in the tumor: pheochromocytoma and metastatic cancer.

conclusionThis is the second published case of pheochromocytoma with tumor-to-tumor metastasis from an invasive ductal carcinoma of the breast. Furthermore, we highlight the importance of awareness of tumor-to-tumor metastasis in pathological diagnosis.

Indexed as

Adrenal Gland NeoplasmsAdrenal GlandsAdultBreastCarcinoma, Ductal, BreastFemaleHumansImmunohistochemistryNeoplasm MetastasisPheochromocytomaTomography, X-Ray ComputedBreast carcinomaPheochromocytomaTumor-to-tumor metastasis

Identifiers

PMID31109373
PMCPMC6528332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.